International Journal of Nanomedicine 2012-01-01

An MRI-visible non-viral vector for targeted Bcl-2 siRNA delivery to neuroblastoma.

Min Shen, Faming Gong, Pengfei Pang, Kangshun Zhu, Xiaochun Meng, Chun Wu, Jin Wang, Hong Shan, Xintao Shuai

Index: Int. J. Nanomedicine 7 , 3319-32, (2012)

Full Text: HTML

Abstract

Polyethylene glycol-grafted polyethylenimine (PEG-g-PEI) which was functionalized with a neuroblastoma cell-specific ligand, the GD2 single chain antibody (scAb(GD2)), was synthesized in order to effectively deliver Bcl-2 siRNA into neuroblastoma cells. This polymer was complexed first with superparamagnetic iron oxide nanoparticle (SPION) to get a MRI-visible targeted non-viral vector (scAb(GD2)-PEG-g-PEI-SPION) and then with Bcl-2 siRNA to form nanoparticles showing low cytotoxicity. The targeting capacity of scAb(GD2)-PEG-g-PEI-SPION was successfully verified in vivo and in vitro by magnetic resonance imaging. The single chain antibody encoded targeted polyplex was more effective in transferring Bcl-2 siRNA than the nontargeting one in SK-N-SH cells, a human neuroblastoma cell line, resulting in a 46.34% inhibition in the expression of Bcl-2 mRNA. Consequently, a high level of cell apoptosis up to 50.76% and a significant suppression of tumor growth were achieved, which indicates that scAb(GD2)-PEG-g-PEI-SPION is a promising magnetic resonance imaging-visible non-viral vector for targeted neuroblastoma siRNA therapy and diagnosis.


Related Compounds

  • GD2-GANGLIOSI...

Related Articles:

Soluble Aβ oligomers are rapidly sequestered from brain ISF in vivo and bind GM1 ganglioside on cellular membranes.

2014-04-16

[Neuron 82(2) , 308-19, (2014)]

Key role for myeloid cells: phase II results of anti-G(D2) antibody 3F8 plus granulocyte-macrophage colony-stimulating factor for chemoresistant osteomedullary neuroblastoma.

2014-11-01

[Int. J. Cancer 135(9) , 2199-205, (2014)]

Fenretinide sensitizes multidrug-resistant human neuroblastoma cells to antibody-independent and ch14.18-mediated NK cell cytotoxicity.

2013-04-01

[J. Mol. Med. 91(4) , 459-72, (2013)]

Validated detection of anti-GD2 antibody ch14.18/CHO in serum of neuroblastoma patients using anti-idiotype antibody ganglidiomab.

2013-12-15

[J. Immunol. Methods 398-399 , 51-9, (2013)]

Uterine leiomyosarcoma diffusely express disialoganglioside GD2 and bind the therapeutic immunocytokine 14.18-IL2: implications for immunotherapy.

2012-07-01

[Cancer Immunol. Immunother. 61(7) , 1149-53, (2012)]

More Articles...